Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling study.

Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling study.

<h4>Background</h4>The United States Preventive Services Task Force supports individualised decision-making for prostate-specific antigen (PSA)-based screening in men aged 55-69. Knowing how the potential benefits and harms of screening vary by an individual's risk of developing pro...

Full description

Bibliographic Details
Main Authors:	Tom Callender, Mark Emberton, Steve Morris, Ros Eeles, Zsofia Kote-Jarai, Paul D P Pharoah, Nora Pashayan
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2019-12-01
Series:	PLoS Medicine
Online Access:	https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1002998&type=printable

Similar Items

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts.
by: Seibert, TM, et al.
Published: (2018)

Impact of germline DNA repair gene variants on prognosis and treatment of men with advanced prostate cancer
by: Emma B. Hansen, et al.
Published: (2023-11-01)

Polygenic hazard score is associated with prostate cancer in multi-ethnic populations
by: Huynh-Le, M, et al.
Published: (2021)

Large-scale transcriptome-wide association study identifies new prostate cancer risk regions
by: Mancuso, N, et al.
Published: (2018)

Benefits and harms of polygenic risk scores in organised cancer screening programmes: a cost-effectiveness analysisResearch in context
by: Changfa Xia, et al.
Published: (2024-03-01)

Relationship of self-reported body size and shape with risk for prostate cancer: A UK case-control study.
by: Mohammad Aladwani, et al.
Published: (2020-01-01)

African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer
by: Karunamuni, RA, et al.
Published: (2020)

The PROFILE feasibility study: targeted screening of men with a family history of prostate cancer
by: Castro, E, et al.
Published: (2016)

The benefits and harms of breast cancer screening Reply
by: Marmot, MG, et al.
Published: (2013)

Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
by: Abel Tesfai, et al.
Published: (2024-05-01)

An updated PREDICT breast cancer prognostic model including the benefits and harms of radiotherapy
by: Isabelle Grootes, et al.
Published: (2024-01-01)

Assessment of harms, benefits and cost-effectiveness of prostate cancer screening: A micro-simulation study of 230 scenarios
by: A. Getaneh, et al.
Published: (2020-07-01)

Relationship of self-reported body size and shape with risk for prostate cancer: A UK case-control study
by: Mohammad Aladwani, et al.
Published: (2020)

The benefits and harms of breast cancer screening: an independent review.
by: Marmot, MG, et al.
Published: (2013)

The benefits and harms of breast cancer screening: an independent review.
by: Independent UK Panel on Breast Cancer Screening
Published: (2012)

The benefits and harms of breast cancer screening: an independent review.
by: Marmot, MG, et al.
Published: (2013)

Harms and benefits of mammographic screening for breast cancer in Brazil.
by: Arn Migowski, et al.
Published: (2024-01-01)

The Benefits and Harms of Lung Cancer Screening in Individuals With Comorbidities
by: Minal S. Kale, MD, MPH, et al.
Published: (2024-03-01)

Harms and benefits of mammographic screening for breast cancer in Brazil
by: Arn Migowski, et al.
Published: (2024-01-01)

Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium.
by: Lophatananon, A, et al.
Published: (2017)

Germline DNA repair gene mutations in young-onset prostate cancer cases in the UK: evidence for a more extensive genetic panel
by: Leongamornlert, D, et al.
Published: (2019)

Knowing You’re Alive’: Students and Self-harming Behaviours
by: Ros Woodward
Published: (2007-04-01)

Relationship of self-reported body size and shape with risk for prostate cancer: A UK case-control study
by: Mohammad Aladwani, et al.
Published: (2020-01-01)

Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis.
by: Orozco, G, et al.
Published: (2013)

Prostate cancer polygenic risk score and prediction of lethal prostate cancer
by: Robert J. Klein, et al.
Published: (2022-04-01)

Performance of polygenic risk scores in screening, prediction, and risk stratification: secondary analysis of data in the Polygenic Score Catalog
by: Harry Hemingway, et al.
Published: (2023-07-01)

Pregnant Women's Perceptions of Harms and Benefits of Mental Health Screening.
by: Dawn Kingston, et al.
Published: (2015-01-01)

Establishing thresholds for important benefits considering the harms of screening interventions
by: Linan Zeng, et al.
Published: (2020-12-01)

“No harm done”: Teachers’ humorous talk about children’s safety
by: Ros Kaye Sullivan
Published: (2014-07-01)

Screening for prostate cancer: what are the benefits ?
by: Murad Lesmana
Published: (2015-12-01)

Benefit and harm of lymphadenectomy in intermediate risk prostate cancer: comparison of five nomograms
by: Branimir Lodeta, et al.
Published: (2023-11-01)

Benefits and Harms of Breast Screening: Focused on Updated Korean Guideline for Breast Cancer Screening
by: Soo-Yeon Kim, et al.
Published: (2016-03-01)

Exploring the benefits, harms, and costs of genomic newborn screening for rare diseases
by: Baple, EL, et al.
Published: (2024)

Do the benefits of screening mammography outweigh the harms of overdiagnosis and unnecessary treatment?
by: Barratt, A, et al.
Published: (2012)

Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening tests
by: Nobbenhuis Marielle AE, et al.
Published: (2011-11-01)

The SCRIPT trial: study protocol for a randomised controlled trial of a polygenic risk score to tailor colorectal cancer screening in primary care
by: Sibel Saya, et al.
Published: (2022-09-01)

Prostate cancer: estimating the benefits of PSA screening.
by: Vickers, A, et al.
Published: (2009)

The effect of sample size on polygenic hazard models for prostate cancer
by: Karunamuni, RA, et al.
Published: (2020)

Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study.
by: Thomas Callender, et al.
Published: (2023-10-01)

Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study
by: Thomas Callender, et al.
Published: (2023-10-01)